Dental Pulp Stem Cell‐Derived Intracellular Vesicles Inhibit OSCC by Delivering PTEN to Suppress PI3K / AKT / mTOR Signalling Pathway
Cell Proliferation · 2026-11 · 59 (11)
DOI: 10.1111/cpr.70248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 10.06.2026. Verfasst von Yu Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center of Regenerative Medicine and Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Mouth Neoplasms, Dental Pulp, Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Project Ministry of Science and Technology of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) represents a globally predominant type of oral malignancy with escalating incidence, featuring aggressive biological behaviour, prominent metastatic potential and poor clinical outcomes. Emerging evidence positions dental pulp stem cell‐sourced intracellular vesicles (DPSC‐IVs) as novel therapeutic vectors in regenerative oncology, citing their low immunogenicity, favourable safety profile and ability to modulate tumour microenvironment. In this study, DPSC‐IVs significantly inhibited OSCC progression both in vitro and in vivo, suppressing tumour cell proliferation, invasion and colony formation while simultaneously promoting apoptosis. Notably, the antitumor effect of DPSC‐IVs was further enhanced by combining them with autophagy inhibitor 3‐methyladenine (3‐MA), which synergistically suppressed the PI3K/AKT/mTOR pathway and enhanced mitochondrial stress while suppressing residual cytoprotective autophagy. Mechanistically, DPSC‐IVs served as carriers of PTEN into OSCC cells, which in turn suppressed oncogenic PI3K/AKT signalling and induced excessive mitophagy. Taken together, this study indicated that DPSC‐IVs could suppress OSCC through dual mechanisms, highlighting their potential as a promising and clinically translatable therapeutic option with advantages in safety and scalable production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Regenerative Medicine and Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan, China.
- Institute of Regenerative and Translational Medicine, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, China.
- Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Yu Luo, Dongjie Fu
Förderung
- State Key Project Ministry of Science and Technology of China
- National Natural Science Foundation of China
Zitieren
APA
Luo, Y., Qin, Q., She, W., Wang, X., Li, X., Shu, C., Li, R., Li, Z., Fu, D., He, Y., & Ye, Q. (2026). Dental Pulp Stem Cell‐Derived Intracellular Vesicles Inhibit OSCC by Delivering PTEN to Suppress PI3K / AKT / mTOR Signalling Pathway. Cell Proliferation, 59(11). https://doi.org/10.1111/cpr.70248
Vancouver
Luo Y, Qin Q, She W, Wang X, Li X, Shu C, et al. Dental Pulp Stem Cell‐Derived Intracellular Vesicles Inhibit OSCC by Delivering PTEN to Suppress PI3K / AKT / mTOR Signalling Pathway. Cell Proliferation. 2026;59(11). doi:10.1111/cpr.70248
BibTeX
@article{Luo2026,
author = {Luo, Yu and Qin, Qiang and She, Wenting and Wang, Xiangying and Li, Xiqin and Shu, Chenxuan and Li, Ruohan and Li, Ziwei and Fu, Dongjie and He, Yan and Ye, Qingsong},
title = {Dental Pulp Stem Cell‐Derived Intracellular Vesicles Inhibit OSCC by Delivering PTEN to Suppress PI3K / AKT / mTOR Signalling Pathway},
journal = {Cell Proliferation},
year = {2026},
volume = {59},
number = {11},
doi = {10.1111/cpr.70248}
}
EUVIMED